Prabhavathi Fernandes - 25 May 2021 Form 4 Insider Report for Ocugen, Inc. (OCGN)

Role
Director
Signature
/s/ Prabhavathi Fernandes by Sanjay Subramanian, her attorney-in-fact
Issuer symbol
OCGN
Transactions as of
25 May 2021
Net transactions value
-$243,675
Form type
4
Filing time
27 May 2021, 16:07:58 UTC
Next filing
10 Jun 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCGN Common Stock Options Exercise $5,460 +19,500 $0.2800 19,500 25 May 2021 Direct
transaction OCGN Common Stock Sale $160,095 -19,500 -100% $8.21 0 25 May 2021 Direct F1
transaction OCGN Common Stock Options Exercise $25,620 +14,000 $1.83 14,000 25 May 2021 Direct
transaction OCGN Commom Stock Sale $114,660 -14,000 -100% $8.19 0 25 May 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCGN Option (Right to Buy) Options Exercise $0 -19,500 -36% $0.000000 34,500 25 May 2021 Common Stock 19,500 $0.2800 Direct F3
transaction OCGN Option (Right to Buy) Options Exercise $0 -14,000 -11% $0.000000 112,000 25 May 2021 Common Stock 14,000 $1.83 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.19 to $8.23. The Reporting Person undertakes to provide Ocugen, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.18 to $8.20. The Reporting Person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F3 The option, initially representing a right to purchase a total of 54,000 shares, vests mothly in equal installments over three years commencing on May 5, 2020, subject to continued service with the Company through the applicable vesting dates.
F4 The option, initially representing a right to purchase a total of 126,000 shares, vests monthly in equal installments over three years commencing on February 1, 2021, subject to continued service with the Company through the applicable vesting dates.